Informa
Track 1: Addressing Global IP Challenges on Crystalline Polymorphs, Epitope Claims, and Markush Patents

Date: Jan 21, 2026

Time: 12:00 PM in India

Description

The evolving global IP landscape presents unique challenges in protecting pharmaceutical innovations, particularly in areas like crystalline polymorphs, epitope claims, and Markush patents. This webinar will explore critical issues such as patentability criteria, enforcement complexities, and jurisdictional differences impacting these specialized claims. Current trends, including heightened scrutiny of polymorph patents, the growing importance of epitope claims in biologics, and the challenges of drafting robust Markush claims in light of evolving patent laws, will be discussed.

Key Learnings
  1. Learn strategies to address patentability and enforcement challenges for crystalline polymorphs, epitope claims, and Markush patents.
  2. Understand current trends and regulatory impacts shaping global IP standards in these areas.
  3. Explore practical approaches to strengthen and optimize pharmaceutical IP strategies.
Moderator:
team-thumb
Dr. Alok Tripathi

Sr. Vice President - IP &Project Management

Centaur Pharmaceuticals Pvt Ltd
Speakers:
team-thumb
Kaushal Joshi

Head IP

Kashiv Bio Sciences
team-thumb
Chandrasekhar Bulusu

AVP- IPR

MSN Laboratories Pvt. Ltd
team-thumb
Dr. Bishram Singh Chauhan

Senior General Manager

Sun Pharmaceutical Industries Ltd
Track 2: From Courtroom to Boardroom: IP Valuation and Compliance with International Standards

Date: Jan 22, 2026

Time: 03:00 PM

Description

Intellectual property is no longer limited to legal protection—it is a central driver of business valuation, competitive advantage, and global expansion. This webinar will unpack how IP assets are valued in today’s high-stakes environment and how companies can stay compliant with evolving international standards. Attendees will gain clarity on how patents, trademarks, and proprietary technologies are assessed, how cross-border regulations influence IP strategy, and how litigation outcomes directly shape the commercial worth of IP portfolios.

Bringing insights from technology, pharma, manufacturing, consumer goods, and research sectors, the session highlights practical challenges organizations face—from managing global filings and audits to navigating infringement disputes and aligning courtroom learnings with corporate decision-making.

Key Learnings
  1. Effective methods to evaluate IP assets and strengthen portfolio value
  2. Key international compliance requirements and their impact on global operations.
  3. Actionable insights connecting litigation outcomes with stronger corporate IP strategies.
Moderator:
team-thumb
Nitin Sharma
Qualcomm
Speakers:
team-thumb
Taruna Gupta

Head IP Governance

TCS
team-thumb
Dr. Amol Mahulkar PhD

Head of Intellectual Property Services

Airbus
team-thumb
Anand Shetty

AVP & Head of Intellectual Property

RIL